Directorate Change

RNS Number:1077I
Baxter International Inc
27 February 2003



Please be advised that James R.Gavin III, M.D., Ph.D. was elected to the Board
of Directors of Baxter International Inc., on February 25,2003.



BAXTER INTERNATIONAL INC. NAMES MOREHOUSE SCHOOL OF MEDICINE PRESIDENT 
TO BOARD OF DIRECTORS


DEERFIELD, Ill., February 25, 2003 -- Baxter International Inc. (NYSE:BAX) today
announced that James R. Gavin III, M.D., Ph.D., has been elected to serve as a
member of its board of directors. Gavin, 57, is currently the president of the
Morehouse School of Medicine in Atlanta, Georgia. 

"We are pleased and proud to have Dr. Gavin join Baxter's board of directors,"
said Harry M. Jansen Kraemer Jr., Baxter chairman and chief executive officer.
"His experience in academia and in the field of medicine, as well as his overall
scientific expertise will add significant value and insight to our team."

Gavin was appointed president of the Morehouse School of Medicine in July 2002.
Prior to that, Gavin served as senior scientific officer at Howard Hughes
Medical Institute, a nonprofit medical research organization, for more than a
decade. In addition to his work as a physician, Gavin has spent much of his
career in academia, holding numerous professorial positions, including posts at
The University of Oklahoma and Washington University School of Medicine. At The
University of Oklahoma, Gavin served as chief of the Diabetes Section, acting
chief of the Section on Endocrinology, Metabolism and Hypertension, and the
William K. Warren Professor for Diabetes Studies. Gavin is a past president of
the American Diabetes Association and is currently chair of the National
Diabetes Education Program (NDEP).

Gavin received a bachelor's degree in chemistry from Livingstone College and a
Ph.D. in Biochemistry from Emory University. He earned a MD degree from Duke
University in 1975 and completed residency at Barnes-Jewish Hospital in St.
Louis, Missouri. 

Gavin is the author or co-author of more than 180 scientific articles and
abstracts, including numerous in-depth studies of diabetes and cardiovascular
disease. He has served on the editorial boards of the American Journal of
Physiology, the American Journal of Medical Sciences and Academic Medicine. 

Gavin is a member of the board of trustees for the Robert Wood Johnson
Foundation and Duke University. He also serves as non-executive chairman of the
board of directors of Equidyne Corporation and a director of MicroIslet, Inc. 

Baxter International Inc., through its subsidiaries, assists health-care
professionals and their patients with treatment of complex medical conditions,
including cancer, hemophilia, immune disorders, kidney disease and trauma. The
company applies its expertise in medical devices, pharmaceuticals and
biotechnology to make a meaningful difference in patients' lives.



FOR ADDITIONAL INFORMATION: 

 

Media Contacts: 


Deborah Spak, 847-948-2349
Liz Meagher,  847-948-3297

 



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
BOAPUUGWPUPWPGM